GPT Healthcare Reports Strong Financial Results for Q4 and Fiscal Year 2026
Kolkata, May 18, 2026: GPT Healthcare Limited (GPT), which operates the ILS Hospitals brand, announced its financial results for the fiscal year ended March 31, 2026. The company reported that its total revenue for the fourth quarter (Q4) of FY26 stood at Rs. 128.0 crore, marking a year-on-year growth of 24.30%.Key Financial Performance for FY26
The company's financial performance for the quarter ended March 31, 2026, demonstrated consistent growth across key metrics. The following table summarizes the key financial highlights for Q4 and the full fiscal year:| Particulars (Rs. Crs) | Q4FY26 | Q4FY25 | Y-o-Y | Q3FY26 | Q-o-Q | FY26 | FY25 | Y-o-Y |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 128.0 | 103.0 | 24.30% | 121.6 | 5.28% | 478.5 | 415.6 | 15.14% |
| EBITDA | 25.0 | 22.2 | 12.27% | 22.2 | 12.95% | 90.1 | 91.8 | (1.86%) |
| EBITDA Margin (%) | 19.53% | 21.62% | 18.20% | 18.84% | 22.10% | |||
| Profit After Tax | 14.7 | 12.9 | 13.00% | 9.4 | 55.48% | 42.2 | 49.9 | (15.43%) |
| PAT Margin (%) | 11.38% | 12.52% | 7.71% | 8.82% | 12.01% |
Operational Achievements
Operational highlights for FY26 included maintaining a competitive and affordable Average Revenue Per Occupied Bed (ARPOB) at INR 39,243. Occupancy rates improved to 55.90% (excluding the newly commenced Raipur facility), supported by higher patient volumes and efficient capacity utilization. Overall occupancy, including the Raipur facility, stood at 45.87%.On the profitability front, the EBITDA margin for FY26 was 23.06% (excluding Raipur) compared to 22.10% in FY25. Significant operational milestones include the successful commencement of operations at the Raipur Hospital during the year. Furthermore, the company launched Respiratory ICU and cardiac care services in ILS Dum Dum during the last quarter.
In technological advancements, cutting-edge robotic surgical technology was installed at the Salt Lake and Howrah Hospital, resulting in the successful performance of over 800 robotic surgeries from the Salt Lake unit. Additionally, an MoU was signed at Jamshedpur Hospital for a 150-bed facility, targeted for commissioning by the end of FY27.
Management Commentary
Commenting on the performance, GPT Healthcare Chairman Dr. Om Tantia noted that the company delivered another quarter of strong and consistent performance, underpinned by disciplined execution and broad-based growth.Dr. Tantia attributed the network occupancy improvement to higher patient volumes, enhanced throughput, and a stronger specialty mix. He stated that the ARPOB recording year-on-year growth, with FY26 ARPOB at ₹ 39,243, aligns with the company's strategy of serving the aspirational middle- to high-income population while maintaining affordability.
The Chairman added that the network continued to strengthen its clinical and technological leadership, completing over 800+ robotic surgeries at ILS Salt Lake to reinforce its position in advanced minimally invasive care. The commissioning of the CTVS (Cardiothoracic and Vascular Surgery) at ILS-Dum Dum ensures that comprehensive cardiac care is provided under one roof.
Hospital Network Overview
GPT Healthcare Limited operates the ILS Hospitals brand, a leading neighborhood tertiary-care hospital platform in Eastern India. The company owns and operates five multi-specialty hospitals: ILS Salt Lake (85 bed), ILS Agartala (205 bed), ILS Dumdum (155 bed), ILS Howrah (116 bed), and ILS Raipur (158 bed). Collectively, the network commands a capacity of over 719 beds across key Eastern Indian markets, providing end-to-end medical solutions and advanced tertiary care services across specialties including oncology, cardiology, renal transplants, and robotic surgeries.GPTHEALTH Stock Price Movement
GPT Healthcare Limited shares today slipped by 1.11% to settle at ₹138.76. The stock saw significant activity, completing the day's trading on a volume of 77,663 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.
Last edited by a moderator: